AST5902 mesylate(2412155-74-7 free base)

TargetMol
Product Code: TAR-T8945L
Supplier: TargetMol
CodeSizePrice
TAR-T8945L-1mg1mg£181.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8945L-5mg5mg£296.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8945L-10mg10mg£428.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8945L-1mL1 mL * 10 mM (in DMSO)£433.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8945L-25mg25mg£661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8945L-50mg50mg£863.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8945L-100mg100mg£1,179.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8945L-500mg500mg£2,303.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
AST5902 mesylate is principal metabolite of Alflutinib in vivo. AST5902 mesylate exerts antineoplastic activity.
CAS:
T8945L
Formula:
C28H33F3N8O5S
Molecular Weight:
650.67
Pathway:
Metabolism
Purity:
0.9946
SMILES:
OS(=O)(C)=O.C=CC(NC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OCC(F)(F)F)N=C1N(C)CCNC)=O
Target:
Drug Metabolite

References

Liu X Y , Guo Z T , Chen Z D , et al. Alflutinib (AST2818), primarily metabolized by CYP3A4, is a potent CYP3A4 inducer[J]. Acta Pharmacologica Sinica, 2020, 41(10).